Search results

  1. Andy

    Breathing therapy for patients with medically unexplained physical symptoms and dysfunctional breathing: A pilot and feasibility trial 2025 Karlsen+

    Abstract Medically unexplained physical symptoms (MUPS) are symptoms without an identifiable organic cause that lead to functional impairment. MUPS is highly prevalent in general practice consultations. This pilot trial aimed to investigate the effectiveness and feasibility of a 5-week breathing...
  2. Andy

    Chronic fatigue: psychometric properties and updated norm values of the Chalder fatigue scale in a cross-sectional sample... 2025 Krakau et al

    "The abbreviation CFQ is commonly used to distinguish it from CFS. The scoring procedure of the instrument allows to differentiate between no fatigue and severe fatigue with an additional item to assess chronicity. According to Cella & Chalder [Citation22], the scale accurately discriminates...
  3. Andy

    Chronic fatigue: psychometric properties and updated norm values of the Chalder fatigue scale in a cross-sectional sample... 2025 Krakau et al

    "Physical (e.g. reduced strength), cognitive (e.g. lack of concentration), and emotional (e.g. lack of energy) fatigue symptoms may be distinguished [Citation4]. The persistence of symptoms for at least six months is considered chronic fatigue (CF). Different criteria and case definitions have...
  4. Andy

    Chronic fatigue: psychometric properties and updated norm values of the Chalder fatigue scale in a cross-sectional sample... 2025 Krakau et al

    Full title: Chronic fatigue: psychometric properties and updated norm values of the Chalder fatigue scale in a cross-sectional sample representative of the German population Abstract Background The Chalder Fatigue Scale (CFQ) is a commonly used self-report instrument assessing the severity and...
  5. Andy

    Mitochondrial Dysfunction & Defects in Mitochondrial Adaptation to Exercise Training in the Muscle of Patients With COPD... 2025 Pomiès et al

    ABSTRACT Aim Chronic obstructive pulmonary disease (COPD) is frequently associated with skeletal muscle dysfunction, having a considerable impact on exercise tolerance and patient prognosis. Mitochondria play a role in skeletal muscle weakness and exercise intolerance in COPD, but the majority...
  6. Andy

    Preprint Mitochondrial Energy Transformation Capacity Influences Brain Activation During Sensory, Affective, and Cognitive Tasks 2025 Bo et al

    Abstract Brain function relies on energy supplied by mitochondrial energy transformation, but how cellular energetics constrain neurological function and cognition remains poorly understood. Genetic defects in mitochondrial DNA cause rare mitochondrial diseases (MitoD) that offer a unique...
  7. Andy

    Randomised feasibility study evaluating eye movement desensitisation and reprocessing therapy for functional neurological disorder (MODIFI) 2025 Cope+

    Abstract Background Functional neurological disorder (FND) is a common neurological presentation with symptoms such as seizures, walking difficulties, limb weakness and cognitive difficulties. Treatments for FND include physiotherapy and psychological therapy. Eye movement desensitisation and...
  8. Andy

    Review The role of sensory attenuation in symptomatic and healthy individuals: a scoping review 2025 Rossi et al

    "PPS, which include conditions like chronic fatigue syndrome, fibromyalgia, and irritable bowel syndrome, often co-occur with or resemble FND. These disorders can range in severity from mild to debilitating, significantly affecting patients’ lives and representing a large portion of healthcare...
  9. Andy

    Review The role of sensory attenuation in symptomatic and healthy individuals: a scoping review 2025 Rossi et al

    "Persistent physical symptoms (PPS), also known as persistent somatic symptoms, are distressing complaints—such as chronic pain, fatigue, or dizziness—that last for at least 6 months and often lack a clear medical explanation (Kube et al., 2020; Löwe et al., 2024; Van den Bergh et al., 2017)...
  10. Andy

    Review The role of sensory attenuation in symptomatic and healthy individuals: a scoping review 2025 Rossi et al

    Background: Persistent physical symptoms (PPS), including functional neurological disorders (FND), chronic pain, and other neurological conditions [e.g., Parkinson’s disease (PD), Huntington’s disease (HD), autism spectrum disorder (ASD), and psychosis], present substantial challenges for...
  11. Andy

    User-Driven Development of a Digital Behavioral Intervention for Chronic Pain: Multimethod Multiphase Study, 2025, Taygar et al

    "The DAHLIA treatment (prototype version 1.0) consisted of 4 self-guided microsessions per week for a total of 24 sessions delivered over 6 weeks. Moreover, patients had weekly contact with a therapist through a 30-minute phone or video call. The digital intervention was offered through the...
  12. Andy

    User-Driven Development of a Digital Behavioral Intervention for Chronic Pain: Multimethod Multiphase Study, 2025, Taygar et al

    Abstract Background: Recent research shows that chronic pain affects 27% of the adult population. For many, pain significantly impairs quality of life and everyday functioning. Behavioral interventions have shown utility, but access remains limited. Digital health solutions can increase reach...
  13. Andy

    Closed UK: DecodeME updates, was recruitment thread.

    No, I don't know, and honestly I would be surprised if he knew himself, given how much is going on at the moment.
  14. Andy

    What resources exist worldwide that hold genetic data on people with ME/CFS?

    Are any forum members aware of any other databases of genetic information for people with ME/CFS (however defined) in existence other than; UK Biobank Lifelines FinnGen Mass General Brigham Biobank Michigan Genomics Initiative Biobank Estonian Biobank Million Veteran Program Thanks for any...
  15. Andy

    Preprint A Proposed Mechanism for ME/CFS Invoking Macrophage Fc-gamma-RI and Interferon Gamma, 2025, Edwards, Cambridge and Cliff

    In an ideal world who would you want to take notice of it? Especially who outside the current ME/CFS research field?
  16. Andy

    Inhibition of the Na+-glucose transporter SGLT2 reduces glucose uptake and IFNγ release from activated human CD4+ T cells 2025 Jin et al

    Glucose uptake in activated CD4+ T cells is essential for increased metabolic needs, synthesis of biomolecules and proliferation. Although, facilitated glucose transport is the predominant route for glucose entry at the time of activation, here we demonstrate role for the sodium-dependent...
  17. Andy

    Prevalence of the anti-CASPR2 autoantibody in patients with somatic symptom disorder accompanied by medically unexplained pain 2025 Shiwaku et al

    Abstract Background Medically unexplained symptoms (MUS) with pain are classified as somatic symptom disorder (SSD) with pain in the field of psychiatry, although an undetected biological basis may underlie at least some of these cases. One such candidate etiology is autoantibodies. Autoantibody...
Back
Top Bottom